Bismuth combo therapy for stomach bug under review
NCT ID NCT07167511
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study looked back at medical records of 1,730 adults with H. pylori infection who received bismuth-containing quadruple therapy as their first treatment. Researchers compared how well different drug combinations worked and what side effects occurred. The goal was to identify which regimen works best in real-world settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bismuth-containing quadruple therapy
- What this could lead to
- If successful, this could help doctors choose the best bismuth-based combination to treat H. pylori infections more effectively.
- What could go wrong
- This is a retrospective review, not a controlled trial, so results may be less reliable. It also does not test a new treatment, only compares existing ones.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a closer look at the stomach spot hidden infections?
- Which antibiotic combo wins against h. pylori? a Head-to-Head test
- Can customizing antibiotics beat stomach bug resistance?
- A supplement may tame the Gut-Wrenching side effects of h. pylori therapy
- Could a fecal transplant beat a stubborn stomach bug?
- AI eye on stomach cancer: 6,000-Person trial tests smarter scopes